Onconomics Plus RGCC Test
Onconomics Plus RGCC Test
What are Identified ?
CTCs, Drug sensitivity, Epigenetic Analysis, and Natural Substance Sensitivity.
Test Results
21 days *
Test Type
Comprehensive Test
Test Frequency
As required for designing the treatment protocol.
Sample Required
Blood sample
Cancer Type
All type of CancersBlood Sample Qty
15-20 ml peripheral whole blood
Sample Test Report
DESCRIPTION
This is the most comprehensive test among all the other tests.
This test is a combination of 3 tests ONCOCOUNT, ONCONOMICS and ONCONOMICS EXTRACTS.
This test provides the detailed report on how effective specific anti-cancer treatments (cytotoxic drugs, monoclonal antibodies, small molecule that inhibitor specific targets (TKI etc). along with the effectiveness of natural substances) are in targeting the Tumour Cells.
This Test also includes the report of the Genetic Profiling of tumour related Genes at epigenetic levelto understand nature of cancer disease.
Onconomics Plus report is a perfect definition of personalised treatment as it gives all the necessary information to the doctors for designing the most accurate treatment plan from Conventional to the Integrative Treatment.
This test is a combination of 3 tests ONCOCOUNT, ONCONOMICS and ONCONOMICS EXTRACTS.
This test provides the detailed report on how effective specific anti-cancer treatments (cytotoxic drugs, monoclonal antibodies, small molecule that inhibitor specific targets (TKI etc). along with the effectiveness of natural substances) are in targeting the Tumour Cells.
This Test also includes the report of the Genetic Profiling of tumour related Genes at epigenetic levelto understand nature of cancer disease.
Onconomics Plus report is a perfect definition of personalised treatment as it gives all the necessary information to the doctors for designing the most accurate treatment plan from Conventional to the Integrative Treatment.
Research Articles
- Circulating tumor cells: biology and clinical significance.
- Flow Cytometric Methods for Circulating Tumor Cell Isolation and Molecular Analysis
- Detection of Circulating Tumor Cells in Patients with Breast, Prostate, Pancreatic, Colon and Melanoma Cancer: A Blinded Comparative Study Using Healthy Donors
- A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer
- Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
- Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study
- Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model.
- Comparison of the growth curves of cancer cells and cancer stem cells
- Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases.
- Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value
- Targeting cancer signaling pathways by natural products: Exploring promising anti- cancer agents.
- Antitumor Potential of Immunomodulatory Natural Products.
- Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value.
- Emerging role of natural products in cancer Immunotherapy.
- Cytostatic and Cytotoxic Natural Products against Cancer Cell Models.
- Comparison of the growth curves of cancer cells and cancer stem cells.
- Natural products targeting cancer stem cells: Implications for cancer chemo prevention and therapeutics.